Piraeus Medical
Maple Grove, US · Founded 2021 · Delaware corporation
Find your way into Piraeus Medical
Sign up to see every warm intro you have to Piraeus Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Piraeus Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
Founders & leadership
Board
RE
Ryan EgelandBoard director
MO
Martin Omid AkhavanBoard director
Reported raises · per SEC filings
Form D private placements$21.1M disclosed across 10 rounds · 2022–2026
▶$10.5MraisedOct 2026 · 25 investors · Other Health CareRule 506(b)
▶$10.5MraisedOct 2026 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer, Director
- Kevin KallmesDirector
- Keith KallmesDirector
- Martin Omid AkhavanDirector
- Ryan EgelandDirector
- Offering amount
- $12M
- Amount sold
- $10.5M
- Minimum investment
- $1K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$662.6KraisedNov 2025 · 4 investors · Other Health CareRule 506(b)
▶$662.6KraisedNov 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan EgelandDirector
- Keith KallmesDirector
- Martin AkhavanDirector
- Kevin KallmesDirector
- Jared HutarExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $662.6K
- Minimum investment
- $1K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$300KraisedSep 2025 · 1 investors · Other Health CareRule 506(b)
▶$300KraisedSep 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan EgelandDirector
- Jared HutarExecutive Officer, Director
- Keith KallmesDirector
- Kevin KallmesDirector
- Martin Omid AkhavanDirector
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $1
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2MraisedFeb 2025 · 65 investors · Other Health CareRule 506(b)
▶$2MraisedFeb 2025 · 65 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer, Director
- Martin Omid AkhavanDirector
- Ryan EgelandDirector
- Keith KallmesDirector
- Kevin KallmesDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $500
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6MraisedJul 2024 · 79 investors · Other Health CareRule 506(b)
▶$6MraisedJul 2024 · 79 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer, Director
- Keith KallmesDirector
- Kevin KallmesDirector
- Ryan EgelandDirector
- Martin Omid AkhavanDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $25K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$450KraisedApr 2024 · 5 investors · Other Health CareRule 506(b)
▶$450KraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer
- Kevin KallmesDirector
- Keith KallmesDirector
- Offering amount
- $3.5M
- Amount sold
- $450K
- Minimum investment
- $5K
- Proceeds to insiders
- $150K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.1KraisedAug 2023 · 2 investors · Other Health CareRule 506(b)
▶$3.1KraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KallmesDirector
- Keith KallmesDirector
- Jared HutarExecutive Officer
- Offering amount
- $3.1K
- Amount sold
- $3.1K
- Minimum investment
- $1
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$150KraisedDec 2022 · 2 investors · Other Health CareRule 506(b)
▶$150KraisedDec 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Keith KallmesExecutive Officer, Director
- Jared HutarExecutive Officer
- Keith KallmesExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $150K
- Minimum investment
- $1K
- Proceeds to insiders
- $200K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Inquis MedicalInquis Medical is a medical device company developing minimally invasive technology to treat thromboembolic disease in the cardiovascular and vascular space. The company is led by a team of medtech entrepreneurs and physicians with experience in endovascular and interventional cardiology devices.
Companies working in the same space as Piraeus Medical.
Frequently asked questions
- What does Piraeus Medical do?
- Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
- How much funding has Piraeus Medical raised?
- Piraeus Medical has disclosed $21.1M raised across 10 rounds.
- Where is Piraeus Medical headquartered?
- Piraeus Medical is headquartered in Maple Grove, US.


